2 options
Parkinson's disease / edited by E. Ronken and G.J.M. van Scharrenburg.
- Format:
- Book
- Conference/Event
- Author/Creator:
- Solvay Pharmaceuticals Conference on Parkinson's Disease, Corporate Author.
- Conference Name:
- Solvay Pharmaceuticals Conference on Parkinson's Disease (1st : 2000 : Como, Italy)
- Series:
- Solvay Pharmaceuticals Conferences ; v. 1.
- Solvay Pharmaceuticals Conferences, 1566-7685 ; v. 1
- Language:
- English
- Subjects (All):
- Parkinson's disease--Congresses.
- Parkinson's disease.
- Physical Description:
- 1 online resource (168 p.)
- Edition:
- 1st ed.
- Place of Publication:
- Amsterdam ; Washington, DC : IOS Press, c2002.
- Language Note:
- English
- Summary:
- This volume contains the proceedings of the first Solvay Pharmaceuticals Research Symposium, and is dedicated to Parkinson's disease. It provides an update of clinical and preclinical research.
- Contents:
- Cover
- Title page
- Preface
- List of Contributors
- Contents
- Conference Preface
- Key-note lecture - Movement Disorders: An Overview
- Part I: Parkinson's Disease - Symptoms, Models and Treatment
- Neurochemical Changes in Parkinson's Disease
- Psychosis and Depression in Parkinson's Disease
- Experimental Models of Parkinson's Disease
- SLV308: A Novel Antiparkinsonian Agent with Antidepressant and Anxiolytic Properties
- Adenosine A[sub(2A)] Receptor Antagonists and Parkinson's Disease
- Part II: Understanding and Influencing Neuro-Degeneration
- Bioenergetics in Neurodegeneration
- Neuronal Cell Death and Apoptosis in Neurodegenerative Diseases
- Animal Models of Neurodegeneration in Parkinson's Disease
- Parkinsonian Features of the Ataxia-Telangiectasia and of the Atm-Deficient Mouse
- Neuroprotection in Parkinson's Disease through Selective Gene Induction
- Part III: Towards Neuroprotective Efficacy
- The RET-Dependent Neuroprotective Effects of GDNF are Mediated by Activation of Proteinkinase B (PKB)/AKT
- An Immortalized Neuronal Cell Line Derived from the Substantia Nigra of an Adult Rat: Application to Cell Transplant Therapy
- Lentiviral Vector Delivery of GDNF in Primate Models of Parkinson's Disease Prevents Neurodegeneration
- Design of Clinical Studies for Neuroprotective Efficacy
- Regulation of Glial Cell Line-Derived Neurotrophic Factor (GDNF) for Dopamine Conservation in Models for Parkinson's Disease
- Concluding Remarks
- Author Index
- A
- B
- C
- D
- E
- F
- H
- J
- K
- L
- M
- N
- O
- P
- R
- S
- T
- V
- W.
- Notes:
- "The First Solvay Pharmaceuticals Conference on "Parkinson's Disease" was held in Como from October 25 to 27, 2000"--Pref.
- Includes bibliographical references and index.
- ISBN:
- 600-00-0515-6
- 9786610505364
- 1-280-50536-2
- 1-60129-451-4
- OCLC:
- 53017729
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.